ジェンマブは革新的な抗体医薬の開発に注力し患者さんの生活を改善することに力を尽くしています
私たちはextranotordinary な未来を共に築くことを使命とし革新的な抗体製品の開発や人々を感動させる抗体医薬品でがんやその他の深刻な病に苦しむ患者さんの生活を根本的に変え治療の未来を切り拓いています
ジェンマブは思いやりがあり率直で患者さんに貢献したいという強い思いを持った人たちがともに働き科学に基づく変化をもたらします大胆さと高潔性を持って行動し新しい未来をつくることを目指すこと がこの使命を果たすために不可欠だと信じています
私たちは大きな志を掲げ楽しくそして思いやりの心を忘れずに日々意義のある仕事に取り組んでいます私たちは個々のユニークな貢献を受け入れそれらを原動力として患者ケアパートナーご家族そして社員のニーズを満たす革新的なソリューションを生み出し育み維持するグローバルな企業文化の構築に努めています
私たちの想いに共鳴し自分らしく活躍できそうだと感じたらぜひ一緒に働きましょう
Position Summary:
The GYN-ONC (Gynecologic Oncology) Product Manager of Genmab KK (Japan) will be work as a Brand champion and Brand leader.
Primary responsibility for all marketing activities to ensure the successful launch of the new product in GYN-ONC in Japan. The position is heavily involved in working with both global and local internal key cross-functional stakeholders as well as external key stakeholders to ensure timely commercial activity planning and execution excellence in achieving the best-in-class launch of the new product.
Primary roles & responsibilities include but are not limited to:-
Leadership of launch readiness planning and execution Lead end-to-end launch readiness activities by coordinating cross-functional teams (including Global Medical Regulatory Market Access Sales Commercial Excellence Supply Chain QA Finance and partners if applicable) to ensure timely and high-quality product launch in Japan Establish and drive a structured launch readiness framework (e.g. governance milestones risk management and decision forums) ensuring clear ownership alignment and accountability across functions Identify critical launch risks gaps and interdependencies early proactively escalate issues and mobilize relevant stakeholders to develop and execute mitigation plans Facilitate launch readiness reviews and progress tracking to ensure organizational preparedness across multiple dimensions Development of a comprehensive market assessment and commercial strategy for the therapeutic area(s) in Japan Plan the commercialization process by working with global and Japanese cross-functional stakeholders to analyze relevant disease and target product profiles competitive landscape patient journeys and purchasing patterns Develop and/or re-evaluate a commercial brand plan (marketing execution readiness/tracking plan) for the Japanese market in collaboration with key global and domestic stakeholders to accurately assess/maximize market opportunities and prepare for potential competitive threats and ensure best-in-class commercialization of products in the Japanese market. Conduct regular market assessments by setting primary/secondary market research objectives gathering insights from KOLs and obtaining and generating key insights from other appropriate sources to further test and fine-tune strategies and tactics to be implemented. Lead the development of KOL engagement and congress strategies to ensure product reputation and broad message penetration Execution and validation of marketing tactics and field operations Work with TLL to support KOL engagement through marketing activities Develop and monitor brand KPIs (market share accounts new patients etc.) to measure success and implement timely corrective actions when necessary (brand KPIs launch tracking dashboards etc.) Plan and execute in-house and co-sponsored congress events Determine direction and plan for materials creation and coordinate with marketing communications Validate strategies and tactics through data analysis via SFE/BI/CI participation in DST meetings or field insight gathering and incorporate/enhance them into the next planning process Collaborate with the training group to set goals to improve MRs understanding of strategy and knowledge level and support the implementation of these goals
Brand OPEX Management
場所
ジェンマブは可能な限り柔軟な働き方を取り入れることで社員のワークライフバランスの向上に取り組んでいます
私たちのオフィスはオープンな環境の中で従業員同士がつながることを目的としていますオフィスでもリモートワークでもお互いにつながることを大切にしイノベーションを生み出します
ジェンマブについて
ジェンマブは革新的抗体医薬を通じて患者さんの生活を向上させることを目指すグローバルバイオテクノロジー企業です
25年間情熱的で革新的そして協力的なチームが次世代抗体技術プラットフォームを開発しトランスレーショナルサイエンス定量科学データサイエンスを活用することで独自のパイプラインを確立してきましたこのパイプラインには二重特異性T細胞エンゲージャーbispecific T-cell engagers抗体薬物複合体ADC次世代免疫チェックポイントモジュレーターエフェクター機能強化抗体などが含まれています
ジェンマブのビジョンは2030年までに人々を感動させる抗体医薬品でがんやその他の深刻な病に苦しむ患者さんの生活を根本的に変えることです
ジェンマブは1999年に設立されたデンマークコペンハーゲンに本社を構え北米ヨーロッパアジア太平洋地域に国際的な拠点を展開しています
ジェンマブでは候補者個人データ及びプライバシーを重要なものと認識しており個人情報の保護に関する法律その他の関係法令を遵守しています個人情報の取扱いにご同意いただいた上ご応募ください
詳細は以下リンク先よりご確認くださいJob Applicant Privacy Notice ()
Required Experience:
Senior Manager
Founded in 1999, we are an international biotech company committed to improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms ... View more